Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteers
about
Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity?Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver functionEffect of erythromycin and rifampicin on monoethylglycinexylidide test.Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients.Lack of in vivo correlation between indinavir and saquinavir exposure and cytochrome P450 3A phenotype as assessed with oral midazolam as a phenotype probe.
P2860
Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteers
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Correlation between midazolam ...... ormation in healthy volunteers
@ast
Correlation between midazolam ...... ormation in healthy volunteers
@en
type
label
Correlation between midazolam ...... ormation in healthy volunteers
@ast
Correlation between midazolam ...... ormation in healthy volunteers
@en
prefLabel
Correlation between midazolam ...... ormation in healthy volunteers
@ast
Correlation between midazolam ...... ormation in healthy volunteers
@en
P2093
P2860
P1476
Correlation between midazolam ...... ormation in healthy volunteers
@en
P2093
A B Johan Groeneveld
Daniel J Touw
Eleonora L Swart
Meindert Danhof
P2860
P304
P356
10.1046/J.0306-5251.2001.01182.X
P407
P577
2002-02-01T00:00:00Z